Clearmind Medicine Inc. Common Shares (CMND)

CMND · BiotechSign Pipeline

Pipeline Overview

Therapeutic Focus: Biotech / Pharmasrc

Signal Snapshot

Clinical Trials (ClinicalTrials.gov aggregate)

Catalyst Records

Publication on Record

ClinicalTrials.gov aggregate as of 2026-09-29. Source

Recent Publications

A common symptom geometry of mood improvement under sertraline and placebo associated with distinct neural patterns. — Psychol Med (2025) PMID 40611472

Get real-time catalyst alerts, analyst signals, dilution risk scores, and full pipeline data for Clearmind Medicine Inc. Common Shares.

Full CMND Data Sign Up Free

Primary Sources

Company identity
Therapeutic indication
Clinical trial aggregate
Publication 40611472

This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.